BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 28195178)

  • 1. Recurrence of Barrett's Esophagus is Rare Following Endoscopic Eradication Therapy Coupled With Effective Reflux Control.
    Komanduri S; Kahrilas PJ; Krishnan K; McGorisk T; Bidari K; Grande D; Keefer L; Pandolfino J
    Am J Gastroenterol; 2017 Apr; 112(4):556-566. PubMed ID: 28195178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cryotherapy and Radiofrequency Ablation for Eradication of Barrett's Esophagus with Dysplasia or Intramucosal Cancer.
    Thota PN; Arora Z; Dumot JA; Falk G; Benjamin T; Goldblum J; Jang S; Lopez R; Vargo JJ
    Dig Dis Sci; 2018 May; 63(5):1311-1319. PubMed ID: 29524114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shorter time to achieve endoscopic eradication is not associated with improved long-term outcomes in Barrett's esophagus.
    Soroush A; Poneros JM; Lightdale CJ; Abrams JA
    Dis Esophagus; 2019 Aug; 32(8):. PubMed ID: 30997483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrence Is Rare Following Complete Eradication of Intestinal Metaplasia in Patients With Barrett's Esophagus and Peaks at 18 Months.
    Wani S; Han S; Kushnir V; Early D; Mullady D; Hammad H; Brauer B; Thaker A; Simon V; Ezekwe E; Hollander T; Wood M; Rastogi A; Edmundowicz S; Muthusamy VR; Komanduri S
    Clin Gastroenterol Hepatol; 2020 Oct; 18(11):2609-2617.e2. PubMed ID: 31982610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety outcomes of multimodal endoscopic eradication therapy in Barrett's esophagus-related neoplasia: a systematic review and pooled analysis.
    Desai M; Saligram S; Gupta N; Vennalaganti P; Bansal A; Choudhary A; Vennelaganti S; He J; Titi M; Maselli R; Qumseya B; Olyaee M; Waxman I; Repici A; Hassan C; Sharma P
    Gastrointest Endosc; 2017 Mar; 85(3):482-495.e4. PubMed ID: 27670227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and durability of radiofrequency ablation for Barrett's Esophagus: systematic review and meta-analysis.
    Orman ES; Li N; Shaheen NJ
    Clin Gastroenterol Hepatol; 2013 Oct; 11(10):1245-55. PubMed ID: 23644385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term follow-up results of stepwise radical endoscopic resection for Barrett's esophagus with early neoplasia.
    Belghazi K; van Vilsteren FGI; Weusten BLAM; Meijer SL; Bergman JJGHM; Pouw RE
    Gastrointest Endosc; 2018 Jan; 87(1):77-84. PubMed ID: 28455160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimized Surveillance Intervals Following Endoscopic Eradication of Dysplastic Barrett's Esophagus: An International Cohort Study.
    Kahn A; Crook J; Heckman MG; Wieczorek MA; Sami S; Snyder D; Agarwal S; Santiago J; Fernandez-Sordo JO; Tan WK; Lansing R; Wang KK; Ragunath K; DiPietro M; Wolfsen H; Ramirez F; Fleischer D; Leggett CL; Iyer PG
    Clin Gastroenterol Hepatol; 2022 Dec; 20(12):2763-2771.e3. PubMed ID: 35245702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of recurrence of dysplasia or cancer in patients with dysplastic Barrett's esophagus following complete eradication of dysplasia: a single-center retrospective cohort study.
    Kobayashi R; Calo NC; Marcon N; Iwaya Y; Shimamura Y; Honda H; Streutker C; Mosko J; May G; Teshima C
    Surg Endosc; 2022 Jul; 36(7):5041-5048. PubMed ID: 34750708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of Radiofrequency Ablation Compared to Liquid Nitrogen Spray Cryotherapy for the Eradication of Dysplasia in Barrett's Esophagus.
    Fasullo M; Shah T; Patel M; Mutha P; Zfass A; Lippman R; Smallfield G
    Dig Dis Sci; 2022 Jun; 67(6):2320-2326. PubMed ID: 33954846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and Incidence of Intestinal Metaplasia and Dysplasia of Gastric Cardia in Patients With Barrett's Esophagus After Endoscopic Therapy.
    Eluri S; Earasi AG; Moist SE; Dellon ES; Shaheen NJ
    Clin Gastroenterol Hepatol; 2020 Jan; 18(1):82-88.e1. PubMed ID: 31077822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Threshold evaluation for optimal number of endoscopic treatment sessions to achieve complete eradication of Barrett's metaplasia.
    Mittal C; Muthusamy VR; Simon VC; Brauer BC; Mullady DK; Hollander T; Sloan I; Kushnir V; Early D; Rastogi A; Hammad HT; Edmundowicz SA; Han S; Thaker AM; Ezekwe E; Wani S; Kwasny MJ; Komanduri S
    Endoscopy; 2022 Oct; 54(10):927-933. PubMed ID: 35135015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis and Management of Low-Grade Dysplasia in Barrett's Esophagus: Expert Review From the Clinical Practice Updates Committee of the American Gastroenterological Association.
    Wani S; Rubenstein JH; Vieth M; Bergman J
    Gastroenterology; 2016 Nov; 151(5):822-835. PubMed ID: 27702561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistent intestinal metaplasia after endoscopic eradication therapy of neoplastic Barrett's esophagus increases the risk of dysplasia recurrence: meta-analysis.
    Sawas T; Alsawas M; Bazerbachi F; Iyer PG; Wang KK; Murad MH; Katzka DA
    Gastrointest Endosc; 2019 May; 89(5):913-925.e6. PubMed ID: 30529044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative risk of recurrence of dysplasia and carcinoma after endoluminal eradication therapy of high-grade dysplasia versus intramucosal carcinoma in Barrett's esophagus.
    Small AJ; Sutherland SE; Hightower JS; Guarner-Argente C; Furth EE; Kochman ML; Forde KA; Bewtra M; Falk GW; Ginsberg GG
    Gastrointest Endosc; 2015 May; 81(5):1158-66.e1-4. PubMed ID: 25650071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intestinal metaplasia recurs infrequently in patients successfully treated for Barrett's esophagus with radiofrequency ablation.
    Orman ES; Kim HP; Bulsiewicz WJ; Cotton CC; Dellon ES; Spacek MB; Chen X; Madanick RD; Pasricha S; Shaheen NJ
    Am J Gastroenterol; 2013 Feb; 108(2):187-95; quiz 196. PubMed ID: 23247578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multifocal nitrous oxide cryoballoon ablation with or without EMR for treatment of neoplastic Barrett's esophagus (with video).
    Canto MI; Shaheen NJ; Almario JA; Voltaggio L; Montgomery E; Lightdale CJ
    Gastrointest Endosc; 2018 Sep; 88(3):438-446.e2. PubMed ID: 29626424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving clinical outcomes of Barrett's esophagus with high dose proton pump inhibitors and cryoablation.
    Snady H
    Ann Med; 2023 Dec; 55(1):1256-1264. PubMed ID: 37232568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes after liquid nitrogen spray cryotherapy in Barrett's esophagus-associated high-grade dysplasia and intramucosal adenocarcinoma: 5-year follow-up.
    Ramay FH; Cui Q; Greenwald BD
    Gastrointest Endosc; 2017 Oct; 86(4):626-632. PubMed ID: 28235596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anatomic location of Barrett's esophagus recurrence after endoscopic eradication therapy: development of a simplified surveillance biopsy strategy.
    Omar M; Thaker AM; Wani S; Simon V; Ezekwe E; Boniface M; Edmundowicz S; Obuch J; Cinnor B; Brauer BC; Wood M; Early DS; Lang GD; Mullady D; Hollander T; Kushnir V; Komanduri S; Muthusamy VR
    Gastrointest Endosc; 2019 Sep; 90(3):395-403. PubMed ID: 31004598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.